Related references
Note: Only part of the references are listed.Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients
Shuzhen Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The Oncotype DX Recurrence Score Is Correlated With a Composite Index Including Routinely Reported Pathobiologic Features
Joseph Geradts et al.
CANCER INVESTIGATION (2010)
A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer
Ping Tang et al.
CANCER INVESTIGATION (2010)
ONCOPOOL - A European database for 16,944 cases of breast cancer
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2010)
Tubular Carcinoma of the Breast: Further Evidence to Support Its Excellent Prognosis
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Tubular carcinoma of the breast: results of a large contemporary series
Sara H. Javid et al.
AMERICAN JOURNAL OF SURGERY (2009)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients
Ido Wolf et al.
CANCER (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Histopathologic variables predict Oncotype DX™ Recurrence Score
Melina B. Flanagan et al.
MODERN PATHOLOGY (2008)
Predicting features of breast cancer with gene expression patterns
Xuesong Lu et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Racial differences in breast cancer survival in women under age 60
Malabika Sarker et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2007)
被撤回的出版物: Genomic signatures to guide the use of chemotherapeutics (Retracted article. See vol. 17, pg. 135, 2011)
Anil Potti et al.
NATURE MEDICINE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients
Maria Stendahl et al.
CLINICAL CANCER RESEARCH (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
Laurel A. Habel et al.
BREAST CANCER RESEARCH (2006)
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
XJ Cui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
G Arpino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy
FJ Esteva et al.
CLINICAL CANCER RESEARCH (2005)
Time-dependent effects on survival in breast carcinoma -: Results of 20 years of follow-up from the Swedish two-county study
J Warwick et al.
CANCER (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A molecular signature of the Nottingham prognostic index in breast cancer
K Yu et al.
CANCER RESEARCH (2004)
New targets for therapy in prostate cancer: Modulation of stromal-epithelial interactions
LWK Chung et al.
UROLOGY (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting
SY Sung et al.
DIFFERENTIATION (2002)
Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells
MM Mueller et al.
DIFFERENTIATION (2002)
Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation
DE Ingber
DIFFERENTIATION (2002)
Long term prognostic value of Nottingham histological grade and its components in early (pT1 N0M0) breast carcinoma
S Frkovic-Grazio et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Prognostic factors in node-negative breast cancer - A review of studies with sample size more than 200 and follow-up more than 5 years
AN Mirza et al.
ANNALS OF SURGERY (2002)
Pathology of preinvasive and excellent prognosis breast cancer
JF Simpson et al.
CURRENT OPINION IN ONCOLOGY (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study
J Lundin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Pathology of preinvasive and excellent-prognosis breast cancer
DL Page et al.
CURRENT OPINION IN ONCOLOGY (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Pathology characteristics that optimize outcome prediction of a breast screening trial
T. J. Anderson et al.
BRITISH JOURNAL OF CANCER (2000)
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189
JF Simpson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
